skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Re: CSS.to

Don't understand why the board approve unanimously on a deal just around average recent price. What's going on?
Read Answer Asked by Dong Sheng on July 25, 2014
Q: Just announced that Transforce (TFI) has offered to take over Contrans (CSS). Board of Contrans supports the deal at approximately $15 per share. Seems low as Contrans closed on Thursday at $14.74.

Who wins: Transforce or Contrans shareholders?
Read Answer Asked on July 25, 2014
Q: Accord financial (ACD) released earnings. Can you comment on its valuation in light of the earnings?
Thanks.
Read Answer Asked by Michael on July 25, 2014
Q: Perhaps you could indulge me with a few suggestions. I have owned TML for ions, but I see insider buying. Should I sell now or perhaps buy more. I have been successful with CWX on buying because of insiders and am up 20% in 2 weeks. Should I sell it now since I see the future 1/4's may be cyclically weaker. I have also owned TMM forever, I am above water but wonder if I should sell and deploy somewhere else. Now that Sentry has put their person on the board do you forsee upside (as in possible merger or takeover)?
I am wondering because CAT remarks have indicated little business in the mining sector, if I should give up on the golds despite the so called good seasonality of the metal at this time. Would you sell the above mentioned positions and deploy elsewhere, and if so what sectors would be appealing. I could add to health, tech,consumer cyclicals, I will await your comments & recommendations. Thank you so much for your objective evaluations, they are very much appreciated.
Read Answer Asked by Maureen on July 25, 2014
Q: Hi Peter and Group. On july 18/14 Bioniche Life Sciences (BNC) received written approval from the FDA to allow it to submit a BLA for marketing approval of it's drug MCNA based on it's current clinical trial data set. This would seem to be important news. What is your current opinion on the company. Thanks
Read Answer Asked by John on July 25, 2014
Q: I would like your input on PSD Today price at 52 week low. Is this a good entry point? I am longterm investor, don't trade regularly. Thank you
Read Answer Asked by marc on July 24, 2014
Q: I believe you offer limited views on US companies - possibly you follow Encore Capital (ECPG) - I have done very well with this stock but, now, it continues to back up even though fundamentals look very solid.
Thanks,
Murray
Read Answer Asked by Murray on July 24, 2014
Q: Is this a good entry point for Spartan Energy? Tx
Read Answer Asked by hugh on July 24, 2014
Q: In February you were positive about Trevali (TV). It seems to be on the move right now. Do you still think it is a good investment? Thanks for your always good advice.
Read Answer Asked by Roland on July 24, 2014
Q: What is your current opinion on Exco Technologies(XTC), and what did you think of the recent 3rd quarter (i.e. did it meet or exceed your expectations)? It currently is about a 10% wieghting in my portfolio (I like to keep a concentrated portfolio of small to mid cap names 10-12 stocks) and is the only exposure I have to the auto sector. Should I continue to hold? Thanks
Read Answer Asked by Scott on July 24, 2014
Q: Would appreciates your thoughts on Exco Technologies Limited XTC financials just released and prospects going forward.
Thanks
John
Read Answer Asked by John on July 24, 2014
Q: Hi Peter and Group
How do you view the $50 million increase in credit recently obrained by Badger. I think company quarter reporting is not too far off. I am down considerably on the stock and wonder if this will be material to their quarterly report Thanks for all your good work. I have learned a lot since taking up membership, I think.
Read Answer Asked by Phyllis on July 24, 2014
Q: hello - I'm going to use one of my questions for a friend Through his employment he has ended up with Edgewater REIT and doesn't know what to do. I see in May you had an initial review of this new REIT. Since then there has been a secondary offering, no insider buying (at least in the market place).

Would you provide an updated review I would be able to share with him.
Read Answer Asked by Mike on July 24, 2014